N,O-Didesmethyltramadol
Metabolite of tramadol
| N,O-Didesmethyltramadol | |
|---|---|
| INN | |
| Drug class | |
| Routes of administration | |
| Pregnancy category | |
| Bioavailability | |
| Metabolism | |
| Elimination half-life | |
| Excretion | |
| Legal status | |
| CAS Number | 36282-47-0 |
| PubChem | 3083540 |
| DrugBank | |
| ChemSpider | 2340865 |
| KEGG | |
N,O-Didesmethyltramadol is a metabolite of the opioid analgesic tramadol. It is formed in the body through the metabolic pathway involving the cytochrome P450 enzyme system. This compound is one of the active metabolites that contribute to the pharmacological effects of tramadol.
Chemical Structure and Properties[edit]

N,O-Didesmethyltramadol is characterized by the removal of two methyl groups from the parent compound, tramadol. The chemical structure consists of a cyclohexanol ring with a methoxyphenyl group and a dimethylamino group. The molecular formula is C13H19NO2, and it has a molecular weight of 221.3 g/mol.
Pharmacology[edit]
N,O-Didesmethyltramadol retains some of the analgesic properties of tramadol, although it is generally less potent. The compound acts on the central nervous system by binding to opioid receptors, primarily the mu-opioid receptor. It also inhibits the reuptake of serotonin and norepinephrine, contributing to its analgesic effects.
Metabolism[edit]
Tramadol is metabolized in the liver by the cytochrome P450 enzyme system, particularly by CYP2D6 and CYP3A4. N,O-Didesmethyltramadol is produced through the demethylation of tramadol, a process that involves the removal of methyl groups. This metabolite is further processed and eventually excreted in the urine.
Clinical Significance[edit]
The presence of N,O-Didesmethyltramadol in the body can influence the overall efficacy and side effect profile of tramadol. Variability in the metabolism of tramadol, due to genetic differences in cytochrome P450 enzymes, can lead to differences in the levels of this metabolite among individuals. This can affect both the therapeutic and adverse effects experienced by patients.
Related Compounds[edit]
Related Pages[edit]
Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa

Tired of being overweight?
Special offer:
Budget GLP-1 weight loss medications
- Semaglutide starting from $29.99/week and up with insurance for visit of $59.99 and up per week self pay.
- Tirzepatide starting from $45.00/week and up (dose dependent) or $69.99/week and up self pay
✔ Same-week appointments, evenings & weekends
Learn more:
- GLP-1 weight loss clinic NYC
- W8MD's NYC medical weight loss
- W8MD Philadelphia GLP-1 shots
- Philadelphia GLP-1 injections
- Affordable GLP-1 shots NYC
|
WikiMD Medical Encyclopedia |
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian